EurekAlert!

Low-dose three-phase brain perfusion imaging and AI-based parameter map generation

Fig. 1. CBF and Tmax maps derived from the model and CTP showing three patients with different cores and low perfusion volumes in the test dataset and the corresponding maximum intensity projection ...
Seeking Alpha

Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of ...

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated ...
Morningstar

MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026

Topline Data from Three Phase 3 Studies Evaluating DT120 Orally Disintegrating Tablet (ODT) for GAD and MDD Expected in 2026: Voyage in 2Q, Panorama in 2H, and Emerge Mid-Year Company Presenting at ...
Electrek

Tesla announces Powerwall 3P with native three-phase inverter

Tesla has announced the Powerwall 3P, a new variant of its home battery with a native three-phase inverter built ...